Clearlake’s Symplr returns to market, all options on the table

Three banks advise the healthcare-focused GRC software company, which is expected to command a more-than $4bn valuation in a potential transaction.

To read this article, you need to sign in.

You should only be asked to sign in once. Not the case? Click here


New to PE Hub?

Register now to read this article and more for free.